Evidence map›Paper›PMID 41838320›Full record

ArticleJournal of thrombosis and thrombolysis2026

Clinical outcomes and missed benefits related to clopidogrel overuse in acute coronary syndrome.

Julia M Umińska, Michał Skrzypek, Klaudyna Grzelakowska, Piotr Adamski, Robert Gajda, Tomasz Białoszyński, Tomasz Dominiak, Bartosz Hudzik, Marek Gierlotka, Miłosz Jaguszewski and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Julia M UmińskaNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Michał SkrzypekDepartment of Biostatistics, Faculty of Public Health, Medical University of Silesia, Katowice, Poland.
Klaudyna GrzelakowskaNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Piotr AdamskiNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Robert GajdaGajda-Med District Hospital, Pułtusk, Poland.
Tomasz BiałoszyńskiClinical Hospital of the Bydgoszcz University of Technology, Bydgoszcz, Poland.
Tomasz DominiakNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland. lek.tomasz.dominiak@gmail.com.
Bartosz HudzikSilesian Center for Heart Diseases, Zabrze, Poland.
Marek GierlotkaDepartment of Cardiology, Institute of Medical Sciences, University of Opole, Opole, Poland.
Miłosz JaguszewskiFirst Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
Ewa LaskowskaNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Piotr NiezgodaNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Przemysław TrzeciakSilesian Center for Heart Diseases, Zabrze, Poland.
Łukasz SzarpakTechnology Transfer Center, The John Paul II Catholic University of Lublin, Lublin, Poland.
Paul A GurbelSinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore and Lifebridge Health System, Baltimore, MD, USA.
Young-Hoon JeongCAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, South Korea.
Zuzana MotovskaCharles University, Prague, Czech Republic.
Udaya TantrySinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore and Lifebridge Health System, Baltimore, MD, USA.
Eliano Pio NavareseNicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Mariusz GąsiorSilesian Center for Heart Diseases, Zabrze, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical outcomeClopidogrelP2Y12 inhibitorPrasugrelTicagrelor

Identifiers

PMID41838320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.